Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia

Press/Media: Press / Media

PeriodOct 9 2019

Media coverage

1

Media coverage

  • TitleAmplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletRiverVest Venture Partners
    CountryUnited States
    Date10/9/19
    PersonsGEORGE THOMPSONIII